Arix Bioscience Plc Arix to present at two IR conferences
01 November 2017 - 6:00PM
RNS Non-Regulatory
TIDMARIX
Arix Bioscience Plc
01 November 2017
Arix Bioscience to present at two investor conferences in
November
LONDON, 1 November 2017: Arix Bioscience plc (LSE: ARIX) ("Arix
Bioscience") a global healthcare and life science company
supporting medical innovation, will present at two investor
conferences in November:
-- Stifel 2017 Healthcare Conference on November 15, 2017 at
11:40 a.m. ET at the Lotte New York Palace Hotel. Jonathan Peacock,
Chairman, will make the presentation, and will participate in
one-on-one investor meetings at the conference on 14 and 15
November.
-- Jefferies 2017 Global Healthcare Conference on 16 November,
at 1:20 p.m. GMT at the Waldorf Hilton in London. Joe Anderson,
CEO, will make the presentation and will participate in one-on-one
investor meetings at the conference during the course of the
day.
For both conferences, audio webcasts and the investor
presentation will be available on Arix's website at
https://arixbioscience.com/presentations on the days of the events.
Webcast replays will be available following the live
presentation.
For more information, please contact:
Arix Bioscience plc
Matthew Cole, Communications Director
+44 (0) 20 7290 1065
Consilium Strategic Communications
Mary-Jane Elliott, Jessica Hodgson, Ivar Milligan
+44 (0)20 3709 5700
arix@consilium-comms.com
About Arix Bioscience plc
Arix Bioscience plc is a global healthcare and life science
company supporting medical innovation. Headquartered in London and
with an office in New York, Arix Bioscience sources, finances and
builds world class healthcare and life science businesses
addressing medical innovation at all stages of development.
Operations are supported by privileged access to breakthrough
academic science and strategic relationships with leading research
accelerators and global pharmaceutical companies.
Arix Bioscience plc is listed on the Main Market of the London
Stock Exchange. For further information, please visit
www.arixbioscience.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRABRBDGISXBGRB
(END) Dow Jones Newswires
November 01, 2017 03:00 ET (07:00 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Apr 2024 to May 2024
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From May 2023 to May 2024